Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Authors	VERBRUGGEN L. C. WANG Y. H. ARMENIAN S. H. EHRHARDT M. J. VAN DER PAL H. J. H. VAN DALEN E. C. VAN AS J. W. BARDI E . BAUST K. BERGER C. CASTAGNOLA E. DEVINE K. A. GEBAUER J . MARCHAK J. G. GLASER A. W. GROLL A. H. HAEUSLER G. M. DEN HARTOGH J. HAUPT R. HJORTH L. KATO M. KEPÁK Tomáš KOOPMAN M. M. W. LANGER T. MAEDA M. MICHEL G. MURACA M. NATHAN P. C. VAN DEN OEVER S. R. PAVASOVIC V. SATO S. SCHULTE F. SUNG L. L. TISSING W. UYTTEBROECK A. MULDER R. L. KUEHNI C. SKINNER R. HUDSON M. M. KREMER L. C. M.
Year of publication	2020
Type	Article in Periodical
Magazine / Source	PEDIATRIC BLOOD & CANCER
MU Faculty or unit	Faculty of Medicine
Citation
Web	https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pbc.28702
Doi	http://dx.doi.org/10.1002/pbc.28702
Keywords	childhood adolescent and young adult (CAYA) cancer survivors; COVID-19; late effects of cancer treatment
Description	Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.